Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26‐Week Results From the Phase 3 PaTHway Trial

Conventional therapy for hypoparathyroidism consisting of active vitamin D and calcium aims to alleviate hypocalcemia but fails to restore normal parathyroid hormone (PTH) physiology. PTH replacement therapy is the ideal physiologic treatment for hypoparathyroidism. The double‐blind, placebo‐control...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Aliya A, Rubin, Mishaela R, Schwarz, Peter, Vokes, Tamara, Shoback, Dolores M, Gagnon, Claudia, Palermo, Andrea, Marcocci, Claudio, Clarke, Bart L, Abbott, Lisa G, Hofbauer, Lorenz C, Kohlmeier, Lynn, Pihl, Susanne, An, Xuebei, Eng, Walter Frank, Smith, Alden R, Ukena, Jenny, Sibley, Christopher T, Shu, Aimee D, Rejnmark, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099823/
https://www.ncbi.nlm.nih.gov/pubmed/36271471
http://dx.doi.org/10.1002/jbmr.4726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099823/
https://www.ncbi.nlm.nih.gov/pubmed/36271471
http://dx.doi.org/10.1002/jbmr.4726

Ejemplares similares